Where I see patients (1)
My reviews
Selected research
-
Association of lower tumor mutation burden with rapid local progression in patients with brain metastases.
Journal of neurosurgery
-
Implantation of engineered adipocytes suppresses tumor progression in cancer models.
Nature biotechnology
-
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast Cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research
Clinical trials
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
rwPFS is defined as the amount of time that elapses between the initiation of ADC1 therapy until the patient experiences disease progression, initiates subsequent anti-cancer therapy, completes study participation, or experiences ...
Recruiting
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast C...
Objective response rate (ORR) is defined as the proportion of participants who experience complete response (CR) or partial response (PR) using Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. The ORR and corresponding t...
Recruiting
Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pe...
Evaluate the ability of tucatinib in combination with trastuzumab/pertuzumab or TDM-1 to prolong intracranial progression free survival (PFS) in patients compared to historical controls. PFS is defined as the time from the day of ...
Recruiting
5.0